News

The FDA approved dihydroergotamine (DHE) mesylate injection (Brekiya) to treat acute migraine (with or without aura) and cluster headaches in adults, Amneal Pharmaceuticals announced Thursday. The ...
Copaxone and generic versions of glatiramer acetate are injected under the skin at 20 mg/mL daily or 40 mg/mL three times a ...
Dual chamber prefilled syringes market Demand 2025 Dual chamber prefilled syringes market is estimated to be valued at $ 184.7 Mn in 2025, and is expected to reach $ 306.6 Mn by 2032, exhibiting a CAG ...
SMi reports: West Pharmaceutical Services to Host a Free Exclusive Webinar on Prefilled Syringe Elastomer Components High-Quality Solutions for Sensitive Molecules, taking place on 16 th July 2020.
3D screen printing provides innovative drug development capabilities that are difficult or impossible to achieve with traditional methods, including complex multi-layered formulations, precision ...
Download this white paper and discover how Stevanato Group's innovative syringe platform answers this challenge.
Healthcare & Pharmaceuticalscategory· April 11, 2025 US FDA approves syringe version of Argenx's immune disorder drug The U.S. Food and Drug Administration has approved a prefilled syringe ...
In early April, the company reported that the FDA had approved a prefilled syringe version of Vyvgart Hytrulo that will allow patients to administer the drug themselves at their homes. Meanwhile ...
Loading It can come in nasal spray, pre-filled syringe or ampoule form, and it can be obtained from most pharmacies free of charge without a prescription under the federal government’s $19.6 ...
The FDA issued a Complete Response Letter (CRL) for the EYLEA HD pre-filled syringe on April 23, 2025. The Company held several teleconferences with the FDA to better understand the contents of ...
Novartis AG, a pharmaceutical powerhouse with a market capitalization of $214.57 billion, reported robust financial results for the first quarter of 2025, with net sales growing by 15% in constant ...